Cleared Traditional

Blood Pressure Monitor (BBZ32-AA01) (K240832) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
73d
Days
Class 2
Risk

K240832 is an FDA 510(k) clearance for the Blood Pressure Monitor (BBZ32-AA01). Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Guangdong Transtek Medical Electronics Co., Ltd. (Zhongshan, CN). The FDA issued a Cleared decision on June 7, 2024 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Guangdong Transtek Medical Electronics Co., Ltd. devices

Submission Details

510(k) Number K240832 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 2024
Decision Date June 07, 2024
Days to Decision 73 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 125d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 269
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K240832.
Blood Pressure Monitor (TMB-2092-G)
K241351 · Guangdong Transtek Medical Electronics Co., Ltd. · Aug 2024
Upper Arm Electronic Blood Pressure Monitor
K241129 · Shenzhen Goodlymed Technology Co., Ltd. · Jul 2024
Electronic Blood Pressure Monitor (Model: PG-800B30, PG-800B38, PG-800B39, PG-800B45, PG-800B46, PG-800B47, PG-800B48, PG-800B53, PG-800B55, PG-800B56, PG-800B57, PG-800B58, PG-800B61)
K240729 · Shenzhen Pango Medical Electronics Co., Ltd. · Jun 2024
Blood Pressure Monitor (TMB-2296-BT)
K240254 · Guangdong Transtek Medical Electronics Co., Ltd. · May 2024
Blood Pressure Monitor (TMB-2287-B)
K240102 · Guangdong Transtek Medical Electronics Co., Ltd. · Apr 2024
Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA)
K234041 · Andon Health Co, Ltd. · Apr 2024